Biofil Chemicals Intrinsic Value
Biofil Chemicals intrinsic value. Biofil Chemicals (BIOFILCHEM) median intrinsic value is ₹9.63 from 7 valuation models (range ₹9–₹44), vs current price ₹29.64 — -67.5% downside (Trading Above Calculated Value), margin of safety -100.0%. Read BIOFILCHEM ex-dividend dates for the complete payout history and dividend yield track record.
BIOFILCHEM Valuation Methods Summary — DCF, Graham Number & P/E
Biofil Chemicals intrinsic value across 7 models vs current price ₹29.64 — upside/downside and value range per method. For current market price and key ratios, visit Biofil Chemicals stock price NSE.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹8.89 | ₹7.11 - ₹10.67 | -70.0% | EPS: ₹0.30, Sector P/E: 22x |
| Book Value Method | asset | ₹27.50 | ₹24.75 - ₹30.25 | -7.2% | Book Value/Share: ₹13.75, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹43.75 | ₹39.38 - ₹48.13 | +47.6% | Revenue/Share: ₹21.88, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹11.86 | ₹10.67 - ₹13.05 | -60.0% | EBITDA: ₹1.00Cr, EV/EBITDA: 10x |
| PEG Ratio Method | growth | ₹8.89 | ₹8.00 - ₹9.78 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹8.89 | ₹8.00 - ₹9.78 | -70.0% | Revenue Growth: 3.9%, Adj P/E: 15.3x |
| Graham Defensive Method | conservative | ₹9.63 | ₹8.67 - ₹10.59 | -67.5% | EPS: ₹0.30, BVPS: ₹13.75 |
BIOFILCHEM Intrinsic Value vs Market Price — All Valuation Models
Biofil Chemicals fair value range ₹9–₹44 vs current market price ₹29.64 across 7 valuation models. Compare with BIOFILCHEM fundamental valuation to assess whether the stock is under or overvalued.
BIOFILCHEM Intrinsic Value Analysis — Undervalued or Overvalued?
Biofil Chemicals median intrinsic value ₹9.63, current price ₹29.64 — Trading Above Calculated Value by 67.5%, margin of safety -100.0%.
What is the intrinsic value of BIOFILCHEM?
Based on our comprehensive analysis using 7 different valuation methods, the estimated intrinsic value of Biofil Chemicals (BIOFILCHEM) is ₹9.63 (median value). With the current market price of ₹29.64, this represents a -67.5% variance from our estimated fair value.
The valuation range spans from ₹8.89 to ₹43.75, indicating ₹8.89 - ₹43.75.
Is BIOFILCHEM undervalued or overvalued?
Based on our multi-method analysis, Biofil Chemicals (BIOFILCHEM) appears to be trading above calculated value by approximately 67.5%.
BIOFILCHEM Financial Health — Key Ratios vs Industry Benchmarks
Biofil Chemicals financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 36.00 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 4.5% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 5.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.81x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
BIOFILCHEM Cash Flow Quality — Operating & Free Cash Flow
Biofil Chemicals operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹-1 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |
| March 2025 | ₹-2 Cr | ₹-2 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹2 Cr | ₹2 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |